Researchers conducted a systematic review to consolidate recent evidence on the preventive benefits of extra virgin olive oil on disease risk factors.
Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023 – Biotech Investments
Medacta Group SA / Key word(s): Half Year Results/Half Year Results 22-Sep-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53